Company’s Alzheimer’s Treatment Study Earns a Flag

August 9, 2022

(Retraction Watch) – A journal has issued an expression of concern for a federally-funded paper on Alzheimer’s disease after a sleuth on PubPeer noted potentially duplicated figures in the article. We shouldn’t forget to mention, as the paper did, that one of the authors – a prominent scientist who happens also to be a co-editor in chief of the journal – has financial ties to a company with interest in the work. That author said the fault lies with the corresponding author. (Read More)